Main Menu
IBI

SEARCH

MEDIA PACK
NEWS
Main Menu

MENU

Current Edition

Upcoming Events

Advertisement

 
 
Alpha

Alpha Biopharma announces series A financing

 AZD3759, AlphaBio’s lead product, is a next-generation small molecule tyrosine kinase inhibitor (TKI). It is specifically designed to treat epidermal growth factor receptor (EGFR) mutation …

22 June 2018 Alpha Announces
Continue Reading →
 
 
 
 
 
 

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Twitter Linkedin
Main Menu
Bio Pharmaceutical Media © 2026, All Rights Reserved – Powered by Teksyte LTD
Tive